🔗 Visit the ClinicalTrials.gov page for NCT04080284
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Integrated genomic characterization of endometrial carcinoma. | Nature | 2013 | 14.29 |
| 2 | Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. | N Engl J Med | 2016 | 3.86 |
| 3 | Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. | Lancet Oncol | 2016 | 1.29 |
| 4 | BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. | Cancer | 2012 | 1.14 |
| 5 | Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. | JAMA Oncol | 2016 | 0.80 |
| 6 | Germline mutations of the DNA repair pathways in uterine serous carcinoma. | Gynecol Oncol | 2016 | 0.76 |
| 7 | Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report. | Eur J Cancer | 2016 | 0.75 |